DYN vs VRDN: stock comparison and AI forecast
Dyne Therapeutics, Inc. (DYN) and Viridian Therapeutics, Inc.\De (VRDN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DYN Dyne Therapeutics, Inc.
- Market Cap
- $3.24B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
VRDN Viridian Therapeutics, Inc.\De
- Price
- $28.55 +67.9% · 6M
- Market Cap
- $3.23B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DYN and VRDN have similar market capitalizations ($3.24B and $3.23B).
- VRDN carries 0.77 times debt per unit of equity, against 0.33 times for DYN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DYN | VRDN |
|---|---|---|
| Market Cap | $3.24B | $3.23B |
| P/B Ratio | 3.48x | 5.57x |
| EPS | $-3.56 | – |
| Book Value/Share | $4.99 | $5.13 |
| Revenue/Share | – | $0.23 |
| FCF/Share | $-3.05 | $-3.03 |
Profitability & Margins
| Metric | DYN | VRDN |
|---|---|---|
| ROE | -65.0% | -78.1% |
| ROA | -49.0% | -44.1% |
| ROIC | -54.2% | -48.9% |
| Operating Margin | – | -1800.4% |
| Net Margin | – | -1742.5% |
| EBT Margin | – | -1800.4% |
Financial Health
| Metric | DYN | VRDN |
|---|---|---|
| Current Ratio | 12.99x | 14.46x |
| Quick Ratio | – | 14.46x |
| D/E Ratio | 0.33x | 0.77x |
| Financial Leverage | 1.33x | 1.77x |
| Interest Coverage | -15.7x | -46.5x |
| Working Capital | $1.09B | $943M |
Cash Flow
| Metric | DYN | VRDN |
|---|---|---|
| Operating Cash Flow | -$565M | -$342M |
| Free Cash Flow | -$569M | -$343M |
| Capital Spending | -$4M | -$2M |
| FCF/Sales | – | -1319.4% |
| CapEx/Sales | – | 7.5% |
Operational Efficiency
| Metric | DYN | VRDN |
|---|---|---|
| Asset Turnover | – | 0.03x |
| Receivables Turnover | – | 0.9x |
| Fixed Assets Turnover | – | 8.8x |
| Days Sales Outstanding | – | 418 days |
Income Statement
| Metric | DYN | VRDN |
|---|---|---|
| Total Revenue | – | $26M |
| Operating Income | -$620M | -$469M |
| Net Income | -$605M | -$454M |
| R&D Expense | $510M | $309M |
| SG&A Expense | – | $247M |
Dividend & Shareholder Information
| Metric | DYN | VRDN |
|---|---|---|
| Shares Outstanding | 187M | 113M |
DYN vs VRDN: stock comparison and AI forecast
Which is bigger, DYN or VRDN?
DYN and VRDN have similar market capitalizations ($3.24B and $3.23B).
Which one does Intratio's AI model rank higher, DYN or VRDN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.